Functions of lipoprotein receptors in neurons

Journal of Lipid Research

Volumn 45, Issue 3, 2004, Pages 403-409

  Beffert, Uwe ^a   Stolt, Peggy C ^b   Herz, Joachim ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apolipoprotein E receptor 2; Reelin; Very low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E RECEPTOR 2; CARRIER PROTEIN; CELL SURFACE PROTEIN; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; REELIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; ENDOCYTOSIS; HUMAN; LIGAND BINDING; MULTIGENE FAMILY; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS E; BRAIN; HUMANS; LIPOPROTEINS; NEURONS; RECEPTORS, LIPOPROTEIN;

EID: 1542409285     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R300017-JLR200     Document Type: Review

References (54)

1. Herz, J. 2001. The LDL receptor gene family: (un)expected signal transducers in the brain. Neuron. 29: 571-581.
2. Corder, E. H., A. M. Saunders, W.J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261: 921-923.
3. Nathan, B. P., K. C. Chang, S. Bellosta, E. Brisch, N. Ge, R. W. Mahley, and R. E. Pitas. 1995. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270: 19791-19799.
4. Nathan, B. P., S. Bellosta, D. A. Sanan, K. H. Weisgraber, R. W. Mahley, and R. E. Pitas. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264: 850-852.
5. Bellosta, S., B. P. Nathan, M. Orth, L. M. Dong, R. W. Mahley, and R. E. Pitas. 1995. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270: 27063-27071.
6. Holtzman, D. M., R. E. Pitas, J. Kilbridge, B. Nathan, R. W. Mahley, G. Bu, and A. L. Schwartz. 1995. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite out-growth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92: 9480-9484.
7. Mauch, D. H., K. Nagler, S. Schumacher, C. Goritz, E. C. Muller, A. Otto, and F. W. Pfrieger. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294: 1354-1357.
8. Hardy, J., and D. Allsop. 1991. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12: 383-388.
9. Simons, M., P. Keller, B. De Strooper, K. Beyreuther, C. G. Dotti, and K. Simons. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA. 95: 6460-6464.
10. LaDu, M. J., M. T. Falduto, A. M. Manelli, C. A. Reardon, G. S. Getz, and D. E. Frail. 1994. Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269: 23403-23406.
11. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90: 1977-1981.
12. Rebeck, G. W., J. S. Reiter, D. K. Strickland, and B. T. Hyman. 1993. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11: 575-580.
13. Bales, K. R., T. Verina, R. C. Dodel, Y. Du, L. Altstiel, M. Bender, P. Hyslop, E. M. Johnstone, S. P. Little, D.J. Cummins, P. Piccardo, B. Ghetti, and S. M. Paul. 1997. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17: 263-264.
14. Bales, K. R., T. Verina, D. J. Cummins, Y. Du, R. C. Dodel, J. Saura, C. E. Fishman, C. A. DeLong, P. Piccardo, V. Petegnief, B. Ghetti, and S. M. Paul. 1999. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 96: 15233-15238.
15. Holtzman, D. M., K. R. Bales, S. Wu, P. Bhat, M. Parsadanian, A. M. Fagan, L. K. Chang, Y. Sun, and S. M. Paul. 1999. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103: R15-R21.
16. Dong, L. M., and K. H. Weisgraber. 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271: 19053-19057.
17. Trommsdorff, M., M. Gotthardt, T. Hiesberger, J. Shelton, W. Stockinger, J. Nimpf, R. E. Hammer, J. A. Richardson, and J. Herz. 1999. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and E receptor 2. Cell. 97: 689-701.
18. D'Arcangelo, G., G. G. Miao, S. C. Chen, H. D. Soares, J. I. Morgan, and T. Curran. 1995. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 374: 719-723.
19. Howell, B. W., R. Hawkes, P. Soriano, and J. A. Cooper. 1997. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature. 389: 733-737.
20. D'Arcangelo, G., R. Homayouni, L. Keshvara, D. S. Rice, M. Sheldon, and T. Curran. 1999. Reelin is a ligand for lipoprotein receptors. Neuron. 24: 471-479.
21. Hiesberger, T., M. Trommsdorff, B. W. Howell, A. Goffinet, M. C. Mumby, J. A. Cooper, and J. Herz. 1999. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron. 24: 481-489.
22. Benhayon, D., S. Magdaleno, and T. Curran. 2003. Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. Brain Res. Mol. Brain Res. 112: 33-45.
23. Howell, B. W., L. M. Lanier, R. Frank, F. B. Gertler, and J. A. Cooper. 1999. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol. 19: 5179-5188.
24. Trommsdorff, M., J. P. Borg, B. Margolis, and J. Herz. 1998. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273: 33556-33560.
25. Howell, B. W., T. M. Herrick, and J. A. Cooper. 1999. Reelin-induced tryosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 13: 643-648.
26. Beffert, U., G. Morfini, H. H. Bock, H. Reyna, S. T. Brady, and J. Herz. 2002. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J. Biol. Chem. 277: 49958-49964.
27. Bock, H. H., and J. Herz. 2003. Reelin activates SRC family tyrosine kinases in neurons. Curr. Biol. 13: 18-26.
28. Bock, H. H., Y Jossin, P. Liu, E. Forster, P. May, A. M. Goffinet, and J. Herz. 2003. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J. Biol. Chem. 278: 38772-38779.
29. Arnaud, L., B. A. Ballif, E. Forster, and J. A. Cooper. 2003. Fyn tyrosine kinase is a critical regulator of Disabled-1 during brain development. Curr. Biol. 13: 9-17.
30. Howell, B. W., T. M. Herrick, J. D. Hildebrand, Y. Zhang, and J. A. Cooper. 2000. Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development. Curr. Biol. 10: 877-885.
31. Howell, B. W., F. B. Gertler, and J. A. Cooper. 1997. Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. EMBO J. 16: 121-132.
32. Mukherjee, A., L. Arnaud, and J. A. Cooper. 2003. Lipid-dependent recruitment of neuronal Src to lipid rafts in the brain. J. Biol. Chem. 278: 40806-40814.
33. Ballif, B. A., L. Arnaud, and J. A. Cooper. 2003. Tyrosine phosphorylation of Disabled-1 is essential for Reelin-stimulated activation of Akt and Src family kinases. Brain Res. Mol. Brain Res. 117: 152-159.
34. Stolt, P. C., H. Jeon, H. K. Song, J. Herz, M.J. Eck, and S. C. Black-low. 2003. Origins of peptide selectivity and phosphoinositide binding revealed by structures of Disabled-1 PTB domain complexes. Structure (Camb). 11: 569-579.
35. Yun, M., L. Keshvara, C. G. Park, Y. M. Zhang, J. B. Dickerson, J. Zheng, C. O. Rock, T. Curran, and H. W. Park. 2003. Crystal structures of the Dab homology domains of mouse disabled 1 and 2. J. Biol. Chem. 278: 36572-36581.
36. Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science. 296: 1655-1657.
37. Lee, V. M., M. Goedert, and J. Q. Trojanowski. 2001. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24: 1121-1159.
38. Brich, J., F. S. Shie, B. W. Howell, R. Li, K. Tus, E. K. Wakeland, L. W. Jin, M. Mumby, G. Churchill, J. Herz, and J. A. Cooper. 2003. Genetic modulation of tau phosphorylation in the mouse. J. Neurosci. 23: 187-192.
39. Homayouni, R., D. S. Rice, M. Sheldon, and T. Curran. 1999. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J. Neurosci. 19: 7507-7515.
40. Stockinger, W., C. Brandes, D. Fasching, M. Hermann, M. Gotthardt, J. Herz, W.J. Schneider, and J. Nimpf. 2000. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J. Biol. Chem. 275: 25625-25632.
41. Gotthardt, M., M. Trommsdorff, M. F. Nevitt, J. Shelton, J. A. Richardson, W. Stockinger, J. Nimpf, and J. Herz. 2000. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 275: 25616-25624.
42. Matsuda, S., T. Yasukawa, Y. Homma, Y. Ito, T. Niikura, T. Hiraki, S. Hirai, S. Ohno, Y. Kita, M. Kawasumi, K. Kouyama, T. Yamamoto, J. M. Kyriakis, and I. Nishimoto. 2001. c-Jun N-terminal kinase (JNK)-interacting protein-1b/isle-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J. Neurosci. 21: 6597-6607.
43. Kim, A. H., T. Sasaki, and M. V. Chao. 2003. JNK-interacting protein 1 promotes Akt1 activation. J. Biol. Chem. 278: 29830-29836.
44. Whitmarsh, A. J., J. Cavanagh, C. Tournier, J. Yasuda, and R. J. Davis. 1998. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281: 1671-1674.
45. Kamal, A., G. B. Stokin, Z. Yang, C. H. Xia, and L. S. Goldstein. 2000. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 28: 449-459.
46. Verhey, K. J., D. Meyer, R. Deehan, J. Blenis, B. J. Schnapp, T. A. Rapoport, and B. Margolis. 2001. Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J. Cell Biol. 152:959-970.
47. Pramatarova, A., P. G. Ochalski, K. Chen, A. Gropman, S. Myers, K. T. Min, and B. W. Howell. 2003. Nck beta interacts with tyrosine-phosphorylated disabled 1 and redistributes in Reelin-stimulated neurons. Mol. Cell. Biol. 23: 7210-7221.
48. Setou, M., T. Nakagawa, D. H. Seog, and N. Hirokawa. 2000. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science. 288: 1796-1802.
49. Weeber, E. J., U. Beffert, C. Jones, J. M. Christian, E. Forster, J. D. Sweatt, and J. Herz. 2002. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277: 39944-39952.
50. Kornau, H. C., L. T. Schenker, M. B. Kennedy, and P. H. Seeburg. 1995. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 269: 1737-1740.
51. Kohr, G., and P. H. Seeburg. 1996. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. 492: 445-452.
52. Wang, Y. T., and M. W. Salter. 1994. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature. 369: 233-235.
53. Boyles, J. K., R. E. Pitas, E. Wilson, R. W. Mahley, and J. M. Taylor. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76: 1501-1513.
54. Boyles, J. K., C. D. Zoellner, L.J. Anderson, L. M. Kosik, R. E. Pitas, K. H. Weisgraber, D. Y. Hui, R. W. Mahley, P. J. Gebicke-Haerter, M. J. Ignatius, and E. M. Shooter. 1989. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83: 1015-1031.